Market Assessment and Capacity Planning for Pancreatic Cancer CDMO Entry
A global Contract Development and Manufacturing Organization (CDMO) sought Stellarix’s support to assess the strategic and financial viability of pancreatic cancer-focused manufacturing devices. Our strategic intelligence enabled demand-driven capacity planning and informed market entry through effective risk mitigation and clear market visibility. Client Background: A global Contract Development and Manufacturing Organization (CDMO) intended to evaluate […]
In-Vivo CAR-T Cell Therapy: The Next Chapter in Oncology
Cell Therapy: Cancer’s New Arsenal Though several therapeutic, biotech, and medtech developments are changing the oncology landscape, in-vivo CAR-T cell therapy stands out for its precision, accessibility, and upscaling capabilities. A step up from ex vivo CAR-T cell therapy, it takes precedence due to its improved toxicity management, manufacturing parameters, and broader scope of clinical […]
In-vivo CAR-T Cell Therapy: New Frontier in Cancer Treatment
Chimeric antigen receptor T-cell (CAR-T) therapy transformed oncology by paving the path for harnessing patients’ own cells to treat B-cell lymphomas, leukemias, and other hematological malignancies. Traditionally, CAR-T cell therapy for cancer relied on ex vivo processes, where a patient’s T-cells are extracted, genetically reprogrammed in an external medium to express synthetic receptors targeting cancer […]
Cancer Vaccines: Advancements in Cancer Immunization
Cancer vaccines are a potential research-based approach to cancer management and therapy that uses the immune system to target and remove cancer cells. These vaccines attempt to prevent the development of certain malignancies by targeting microorganisms linked to these diseases, such as the HPV vaccine, which is intended to reduce cervical cancer incidence. Furthermore, cancer […]
Live Biotherapeutics: Fighting Cancer With Bacteria
Live bio-therapeutics indulging microbes have become the treatment of choice for cancer due to the toxic adversary caused by traditional treatment methods like- chemotherapy, radiation, and surgery. The modified/unmodified microbes have become valuable to the cancer treatment armamentarium. Scientists have identified live bacteria such as Bacillus spp., Clostridium spp., Escherichia coli, Listeria spp., and Salmonella spp. It is […]
Cancer Therapy: Innovations, Challenges, and Hope
Overview Cancer therapy is evolving through advances in targeted treatments, immunotherapy, and personalized medicine. These approaches aim to address the specific mechanisms driving cancer growth, harness the immune system, and tailor treatment to individual patients’ characteristics. However, drug resistance and the complexity of cancer remain significant challenges in developing effective therapies. Emerging approaches such as […]
Therapeutic Potential of Epigenetic Reprogramming
Overview Epigenetic reprogramming is emerging as a promising approach to therapeutic innovation by modifying gene activity without altering the underlying DNA sequence. Advances in epigenome editing are enabling researchers to investigate how cellular functions can be redirected to address complex diseases. From cancer treatment to cardiovascular research and regenerative applications, multiple technologies are expanding the […]